June 7, 2023
RegMed Investors’ (RMi) closing bell: the cell and gene therapy sector initiating a fifth (5th) uplifted session
June 6, 2023
RegMed Investors’ (RMi) closing bell: cell and gene therapy swells as Nasdaq uplifts
June 3, 2023
RegMed Investors’ (RMi) closing bell: investors escaped the debt ceiling conflagration helping sentiment
May 31, 2023
RegMed Investors’ (RMi) closing bell: deal or no deal
May 25, 2023
RegMed Investors’ (RMi) closing bell: another breakdown in sector’s share pricing
May 24, 2023
RegMed Investors’ (RMi) closing bell: sector share pricing rolls downhill
May 23, 2023
RegMed Investors’ (RMi) closing bell: sector is affected by debt ceiling “talks” insinuating a Biden default
May 22, 2023
RegMed Investors’ (RMi) closing bell: Sector runs to the upside versus sitting on the sidelines
May 18, 2023
RegMed Investors’ (RMi) closing bell: too many factors are calling the ball on share pricing
May 16, 2023
RegMed Investors’ (RMi) closing bell: biotech, cell and gene therapy sector sinks
May 15, 2023
RegMed Investors’ (RMi) closing bell: a waiting game
May 12, 2023
RegMed Investors’ (RMi) closing bell: sector sentiment and conviction dampened by economic/inflation headwinds
May 11, 2023
RegMed Investors’ (RMi) closing bell: under pressure with share pricing deceleration
May 10, 2023
RegMed Investors’ (RMi) closing bell: economic expectation influences share pricing reality
May 5, 2023
RegMed Investors’ (RMi) closing bell: sentiment is overstretched yet, a solid Friday upside response
May 4, 2023
RegMed Investors’ (RMi) closing bell: sector barely wavers by earnings outcomes
1 hour 12 min ago
RMi Closing Bell: Rattled
3 hours 34 min ago
RMi Research Note: Capricor Therapeutics (CAPR) overvalued, overbought and headed to a BIGGER slide
My motto … never leave an investor uninformed! I say today what others won’t, so you can do what others can’t.
My name is Henry McCusker; I endorse these opinions under my own name and with a subscription based membership.
Do you have an opinion you would like to share with us? We would like to hear from you.
Please e-mail us at hwm@regmedinvestors.com.
Editor and Publisher ... Henry McCusker enters his tenth (10th) year at RegMed Investors
© 2025 RegMed Investors (regmedinvestors.com), all rights are reserved.
RegMed Investors (RMi) or Regmedinvestors.com content is the intellectual property of Henry McCusker. Any copying, republication or redistribution of RMI’s content, including by framing or similar means, is expressly prohibited without the prior written consent of Scimitar; who also shall not be liable for any errors or delays in content, or for any actions taken in reliance thereon. For additional information on other Scimitar media services or reposting please email hwm@regmedinvestors.com.
The information included above as well as individual companies and/or securities mentioned should be construed as guidance in RMi reviews.
The facts stated and the opinions given in this publication are based on data and information considered to be reliable and have been carefully worked into my qualitative analyses and prognoses. However, no guarantee can be given as to their fairness, accuracy or completeness.
Henry McCusker, the editor and publisher of RegMed Investors does not hold or have positions in securities referred to in this publication.